Peripheral T/NK Cell Lymphoma (R/R PTCL) Recruiting Phase 2 Trials for Linperlisib (DB17235)

IndicationStatusPhase
DBCOND0146912 (Peripheral T/NK Cell Lymphoma (R/R PTCL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05274997A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell LymphomaTreatment